51. Systemic lupus erythematosus and pregnancy at the Royal Women's Hospital, Brisbane 1979-1989.
- Author
-
Nicklin JL
- Subjects
- Abortion, Spontaneous epidemiology, Abortion, Spontaneous etiology, Abortion, Therapeutic statistics & numerical data, Female, Fetal Death epidemiology, Fetal Death etiology, Fetal Growth Retardation epidemiology, Fetal Growth Retardation etiology, Hospitals, Maternity, Humans, Incidence, Lupus Erythematosus, Systemic classification, Lupus Erythematosus, Systemic drug therapy, Pregnancy, Pregnancy Complications classification, Pregnancy Complications drug therapy, Pregnancy, Ectopic epidemiology, Pregnancy, Ectopic etiology, Queensland epidemiology, Lupus Erythematosus, Systemic epidemiology, Pregnancy Complications epidemiology, Pregnancy Outcome
- Abstract
The management and obstetric outcome of 17 patients with systemic lupus erythematosus (SLE) complicating 42 pregnancies is presented. Similar to world figures there was a 14.3% incidence of therapeutic abortion, a 4.8% incidence of ectopic pregnancy, a 16.7% incidence of spontaneous abortion, a 23.8% incidence of prematurity, a 4.8% incidence of fetal death in utero (FDIU) and a 9.5% incidence of intrauterine growth retardation (IUGR). In patients with antiphospholipid antibodies the obstetric outcome was significantly worse. Pregnancies complicated by preexisting renal compromise all concluded with an adverse outcome to the conceptus. In light of the experiences at the Royal Women's Hospital and a review of the world literature, the need for a standardized approach to SLE in pregnancy and more importantly the need for a large, prospective randomized trial of low dose aspirin in these pregnancies is highlighted.
- Published
- 1991
- Full Text
- View/download PDF